糖尿病治疗药的全球市场规模调查，各产品，各地区预测2022-2028

全球糖尿病治疗药市场在2021年估算为1兆3,898亿3,000万美元，在预测期间的2022-2028年预计将以10.40％以上健全的成长率增长。

本调查的目的是定义近年来各个细分市场和国家的市场规模，并在未来几年预测它们的价值。本报告设计内容涵盖调查对象国家产业的定性和定量双方面。

此外也提供市场未来性的成长促进因素和课题等重要方面相关之详细资讯。再加上主要企业的竞争情形和提供产品之详细分析，并涵括利害关係者投资所需的微观市场潜在机会。详细的市场区隔和子区隔如下列。

各产品

注射剂

口服糖尿病治疗药

各地区

北美

美国

加拿大

欧洲

英国

德国

法国

西班牙

义大利

其他欧洲

亚洲·太平洋

中国

印度

日本

澳洲

韩国

其他亚太地区

南美

巴西

墨西哥

其他地区

本调查涵括年份如下。

实际成果年-2018年，2019年，2020年

基准年-2021

预测期间-从2022年到2028年

本报告，全球糖尿病治疗药市场主要读者。

主要的咨询公司·顾问

大企业，中坚企业，中小企业

创业投资

增值转售商(VAR)

第三方知识供应商

投资银行家

投资者

目录

第1章 摘要整理

• 市场概述
• 全球市场·市场区隔的估计·预测，2020-2028年
  • 糖尿病治疗药的全球市场:各地区，2020-2028年
  • 糖尿病治疗药的全球市场:各产品):2020-2028年
• 主要趋势
• 调查手法
• 调查前提条件

第2章 糖尿病治疗药的全球市场定义和范围

• 调查的目的
• 市场定义和范围
  • 调查目标范围
  • 产业的演进
• 调查对象年
• 货币换算比率

第3章 全球糖尿病治疗药市场力学

• 糖尿病治疗药市场影响分析(2020-2028年)
  • 推动市场要素
  • 市场课题
  • 市场机会

第4章 全球糖尿病治疗药市场产业分析

• 波特的5力模式
  • 供给企业谈判力
  • 买方议价能力
  • 新加入厂商业者的威胁
  • 替代品的威胁
  • 竞争企业间的敌对关係
  • 波特五力分析的未来性方法(2018-2028年)
• PEST分析
  • 政治
  • 经济
  • 社会
  • 技术性
• 投资采用模式
• 分析师的结论·建议
• 顶级投资机会
• 主要成功策略

第5章 风险评估:COVID-19衝击

• COVID-19对产业带来的整体影响的评估
• COVID-19以前和COVID-19以后的市场情景

第6章 糖尿病治疗药的全球市场:各产品

• 市场概述
• 糖尿病治疗药的全球市场:各产品，性能-潜在力分析
• 糖尿病治疗药的全球市场，各产品估计·预测2018～2028年
• 糖尿病治疗药市场，子区隔分析
  • 注射剂
  • 口服抗糖尿病药物

第7章 糖尿病治疗药的全球市场:各地区分析

• 糖尿病治疗药市场，各地区市场概述
• 北美
  • 美国
    • 产品估计·预测，2018年～2028年
  • 加拿大
• 欧洲糖尿病治疗药市场概述
  • 英国
  • 德国
  • 法国
  • 西班牙
  • 义大利
  • 其他的欧洲地区
• 亚太地区的糖尿病治疗药市场概述
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国
  • 其他亚太地区
• 南美的糖尿病治疗药市场概述
  • 巴西
  • 墨西哥
• 全球其他地区

第8章 竞争资讯

• 顶级市场策略
• 企业简介
  • Astrazenecaplc
    • 主要的资讯
    • 概要
    • 根据财务(资料的得到情形不同)
    • 产品概要
    • 最近的开发情形
  • Boehringer Ingelheim Gmbh
  • Eli Lilly And Company
  • GlaxoSmithKline plc
  • Novartis AG
  • Novo Nordisk
  • Sanofi S.A
  • Takeda Pharmaceutical Company Limited
  • Johnson And Johnson MD&D
  • Merck And Co.

第9章 调查流程

• 调查流程
  • 资料探勘
  • 分析
  • 市场估计
  • 验证
  • 出版
• 调查属性
• 调查前提条件

Global Diabetes Therapeutics Market is valued approximately USD 1389.83 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 10.40 % over the forecast period 2022-2028. Diabetes Therapeutics refers to various treatment techniques utilized for the treatment of a diabetic patient such as insulin injections, pumps, and oral drugs among others. Diabetes is a chronic metabolic disease that occurs when the pancreas is no longer able to produce insulin or the body is unable to fully utilize the insulin it produces. it is characterized by an elevated level of glucose that causes ill impacts on the heart. Increase in prevalence of diabetes due to increasing obesity among people caused by unhealthy diets and sedentary lifestyles. The increasing number of programs initiated by various healthcare organizations for raising awareness about diabetes. For Instance: according to the International Diabetes Federation (IDF), it was reported that approximately 537 million adults (20-79 years) are living with diabetes, and the number of people suffering from diabetes is projected to rise to 643 million by 2030 and 783 million by 2045. In addition, the Centers for Disease Control and Prevention (CDC) in the U.S. announced the launch of the National Diabetes Prevention Program (National DPP), along with the partnership of public and private organizations. The National Diabetes Prevention Program aims to prevent or delay type 2 diabetes. Also, the increase in research and development in the healthcare sector, the introduction of advanced drug in the market and new product approvals in the market contribute to the growth of the diabetes market. Rise in the geriatric and obese population. according to the Center for Aging Better, in 2021, there are almost 12 million people aged 65 and over in the UK, with 3.2 million aged 80 and over thus increase in several geriatric populations is likely to increase the market growth during the forecast period. However, Various side effects associated with the long-term use of anti-diabetes drug impedes the growth of the market over the forecast period of 2022-2028.

The key regions considered for the Global Diabetes Therapeutics Market study includes Asia Pacific, North America, Europe, Latin America and the Rest of the World. North America dominated the global insulin therapeutics market in 2021, owing to the high prevalence of diabetes in the region because of the sedentary lifestyle and the launch of new drugs in the region. The United States is expected to grow tremendously during the forecast period, owing to factors, such as the high prevalence of obesity and increasing awareness regarding diabetes care in the region.

Major market players included in this report are:

Astrazeneca plc

Boehringer Ingelheim Gmbh

Eli Lilly And Company

GlaxoSmithKline plc

Novartis AG

Novo Nordisk

Sanofi S.A

Takeda Pharmaceutical Company Limited

Johnson And Johnson MD&D

Merck And Co.

The objective of the study is to define the market sizes of different segments & countries in recent years and to forecast the values for the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of the competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Product:

Injectables

Oral antidiabetic Drugs

By Region:

North America

U.S.

Canada

Europe

UK

Germany

France

Spain

Italy

ROE

Asia Pacific

China

India

Japan

Australia

South Korea

RoAPAC

Latin America

Brazil

Mexico

Rest of the World

Furthermore, years considered for the study are as follows:

Historical year - 2018, 2019, 2020

Base year - 2021

Forecast period: - 2022 to 2028

Target Audience of the Global Diabetes Therapeutics Market in Market Study:

Key Consulting Companies & Advisors

Large, medium-sized, and small enterprises

Venture capitalists

Value-Added Resellers (VARs)

Third-party knowledge providers

Investment bankers

Investors

Table of Contents

Chapter 1. Executive Summary

• 1.1. Market Snapshot
• 1.2. Global & Segmental Market Estimates & Forecasts, 2020-2028 (USD Billion)
  • 1.2.1. Global Diabetes Therapeutics Market, by Region, 2020-2028 (USD Billion)
  • 1.2.2. Global Diabetes Therapeutics Market, by Product, 2020-2028 (USD Billion)
• 1.3. Key Trends
• 1.4. Estimation Methodology
• 1.5. Research Assumption

Chapter 2. Global Diabetes Therapeutics Market Definition and Scope

• 2.1. Objective of the Study
• 2.2. Market Definition & Scope
  • 2.2.1. Scope of the Study
  • 2.2.2. Industry Evolution
• 2.3. Years Considered for the Study
• 2.4. Currency Conversion Rates

Chapter 3. Global Diabetes Therapeutics Market Dynamics

• 3.1. Diabetes Therapeutics Market Impact Analysis (2020-2028)
  • 3.1.1. Market Drivers
    • 3.1.1.1. Increasing prevalence of diabetes
    • 3.1.1.2. Favourable initiatives from government authorities.
  • 3.1.2. Market Challenges
    • 3.1.2.1. Side effects associated with long-term use of anti-diabetes drug.
  • 3.1.3. Market Opportunities
    • 3.1.3.1. Growing number of R&D activities in healthcare sector
    • 3.1.3.2. Increasing number of geriatric and obese individuals.

Chapter 4. Global Diabetes Therapeutics Market Industry Analysis

• 4.1. Porter's 5 Force Model
  • 4.1.1. Bargaining Power of Suppliers
  • 4.1.2. Bargaining Power of Buyers
  • 4.1.3. Threat of New Entrants
  • 4.1.4. Threat of Substitutes
  • 4.1.5. Competitive Rivalry
  • 4.1.6. Futuristic Approach to Porter's 5 Force Model (2018-2028)
• 4.2. PEST Analysis
  • 4.2.1. Political
  • 4.2.2. Economical
  • 4.2.3. Social
  • 4.2.4. Technological
• 4.3. Investment Adoption Model
• 4.4. Analyst Recommendation & Conclusion
• 4.5. Top investment opportunity
• 4.6. Top winning strategies

Chapter 5. Risk Assessment: COVID-19 Impact

• 5.1.1. Assessment of the overall impact of COVID-19 on the industry
• 5.1.2. Pre COVID-19 and post COVID-19 market scenario

Chapter 6. Global Diabetes Therapeutics Market, by Product

• 6.1. Market Snapshot
• 6.2. Global Diabetes Therapeutics Market by Product, Performance - Potential Analysis
• 6.3. Global Diabetes Therapeutics Market Estimates & Forecasts by Product 2018-2028 (USD Billion)
• 6.4. Diabetes Therapeutics Market, Sub Segment Analysis
  • 6.4.1. Injectables
  • 6.4.2. Oral antidiabetic Drugs

Chapter 7. Global Diabetes Therapeutics Market, Regional Analysis

• 7.1. Diabetes Therapeutics Market, Regional Market Snapshot
• 7.2. North America Diabetes Therapeutics Market
  • 7.2.1. U.S. Diabetes Therapeutics Market
    • 7.2.1.1. Product estimates & forecasts, 2018-2028
  • 7.2.2. Canada Diabetes Therapeutics Market
• 7.3. Europe Diabetes Therapeutics Market Snapshot
  • 7.3.1. U.K. Diabetes Therapeutics Market
  • 7.3.2. Germany Diabetes Therapeutics Market
  • 7.3.3. France Diabetes Therapeutics Market
  • 7.3.4. Spain Diabetes Therapeutics Market
  • 7.3.5. Italy Diabetes Therapeutics Market
  • 7.3.6. Rest of Europe Diabetes Therapeutics Market
• 7.4. Asia-Pacific Diabetes Therapeutics Market Snapshot
  • 7.4.1. China Diabetes Therapeutics Market
  • 7.4.2. India Diabetes Therapeutics Market
  • 7.4.3. Japan Diabetes Therapeutics Market
  • 7.4.4. Australia Diabetes Therapeutics Market
  • 7.4.5. South Korea Diabetes Therapeutics Market
  • 7.4.6. Rest of Asia Pacific Diabetes Therapeutics Market
• 7.5. Latin America Diabetes Therapeutics Market Snapshot
  • 7.5.1. Brazil Diabetes Therapeutics Market
  • 7.5.2. Mexico Diabetes Therapeutics Market
• 7.6. Rest of The World Diabetes Therapeutics Market

Chapter 8. Competitive Intelligence

• 8.1. Top Market Strategies
• 8.2. Company Profiles
  • 8.2.1. Astrazenecaplc
    • 8.2.1.1. Key Information
    • 8.2.1.2. Overview
    • 8.2.1.3. Financial (Subject to Data Availability)
    • 8.2.1.4. Product Summary
    • 8.2.1.5. Recent Developments
  • 8.2.2. Boehringer Ingelheim Gmbh
  • 8.2.3. Eli Lilly And Company
  • 8.2.4. GlaxoSmithKline plc
  • 8.2.5. Novartis AG
  • 8.2.6. Novo Nordisk
  • 8.2.7. Sanofi S.A
  • 8.2.8. Takeda Pharmaceutical Company Limited
  • 8.2.9. Johnson And Johnson MD&D
  • 8.2.10. Merck And Co.

Chapter 9. Research Process

• 9.1. Research Process
  • 9.1.1. Data Mining
  • 9.1.2. Analysis
  • 9.1.3. Market Estimation
  • 9.1.4. Validation
  • 9.1.5. Publishing
• 9.2. Research Attributes
• 9.3. Research Assumption

LIST OF TABLES

• TABLE 1. Global Diabetes Therapeutics Market, report scope
• TABLE 2. Global Diabetes Therapeutics Market estimates & forecasts by Region 2018-2028 (USD Billion)
• TABLE 3. Global Diabetes Therapeutics Market estimates & forecasts by Product 2018-2028 (USD Billion)
• TABLE 4. Global Diabetes Therapeutics Market by segment, estimates & forecasts, 2018-2028 (USD Billion)
• TABLE 5. Global Diabetes Therapeutics Market by region, estimates & forecasts, 2018-2028 (USD Billion)
• TABLE 6. Global Diabetes Therapeutics Market by segment, estimates & forecasts, 2018-2028 (USD Billion)
• TABLE 7. Global Diabetes Therapeutics Market by region, estimates & forecasts, 2018-2028 (USD Billion)
• TABLE 8. Global Diabetes Therapeutics Market by segment, estimates & forecasts, 2018-2028 (USD Billion)
• TABLE 9. Global Diabetes Therapeutics Market by region, estimates & forecasts, 2018-2028 (USD Billion)
• TABLE 10. Global Diabetes Therapeutics Market by segment, estimates & forecasts, 2018-2028 (USD Billion)
• TABLE 11. Global Diabetes Therapeutics Market by region, estimates & forecasts, 2018-2028 (USD Billion)
• TABLE 12. Global Diabetes Therapeutics Market by segment, estimates & forecasts, 2018-2028 (USD Billion)
• TABLE 13. Global Diabetes Therapeutics Market by region, estimates & forecasts, 2018-2028 (USD Billion)
• TABLE 14. U.S. Diabetes Therapeutics Market estimates & forecasts, 2018-2028 (USD Billion)
• TABLE 15. U.S. Diabetes Therapeutics Market estimates & forecasts by segment 2018-2028 (USD Billion)
• TABLE 16. U.S. Diabetes Therapeutics Market estimates & forecasts by segment 2018-2028 (USD Billion)
• TABLE 17. Canada Diabetes Therapeutics Market estimates & forecasts, 2018-2028 (USD Billion)
• TABLE 18. Canada Diabetes Therapeutics Market estimates & forecasts by segment 2018-2028 (USD Billion)
• TABLE 19. Canada Diabetes Therapeutics Market estimates & forecasts by segment 2018-2028 (USD Billion)
• TABLE 20. UK Diabetes Therapeutics Market estimates & forecasts, 2018-2028 (USD Billion)
• TABLE 21. UK Diabetes Therapeutics Market estimates & forecasts by segment 2018-2028 (USD Billion)
• TABLE 22. UK Diabetes Therapeutics Market estimates & forecasts by segment 2018-2028 (USD Billion)
• TABLE 23. Germany Diabetes Therapeutics Market estimates & forecasts, 2018-2028 (USD Billion)
• TABLE 24. Germany Diabetes Therapeutics Market estimates & forecasts by segment 2018-2028 (USD Billion)
• TABLE 25. Germany Diabetes Therapeutics Market estimates & forecasts by segment 2018-2028 (USD Billion)
• TABLE 26. RoE Diabetes Therapeutics Market estimates & forecasts, 2018-2028 (USD Billion)
• TABLE 27. RoE Diabetes Therapeutics Market estimates & forecasts by segment 2018-2028 (USD Billion)
• TABLE 28. RoE Diabetes Therapeutics Market estimates & forecasts by segment 2018-2028 (USD Billion)
• TABLE 29. China Diabetes Therapeutics Market estimates & forecasts, 2018-2028 (USD Billion)
• TABLE 30. China Diabetes Therapeutics Market estimates & forecasts by segment 2018-2028 (USD Billion)
• TABLE 31. China Diabetes Therapeutics Market estimates & forecasts by segment 2018-2028 (USD Billion)
• TABLE 32. India Diabetes Therapeutics Market estimates & forecasts, 2018-2028 (USD Billion)
• TABLE 33. India Diabetes Therapeutics Market estimates & forecasts by segment 2018-2028 (USD Billion)
• TABLE 34. India Diabetes Therapeutics Market estimates & forecasts by segment 2018-2028 (USD Billion)
• TABLE 35. Japan Diabetes Therapeutics Market estimates & forecasts, 2018-2028 (USD Billion)
• TABLE 36. Japan Diabetes Therapeutics Market estimates & forecasts by segment 2018-2028 (USD Billion)
• TABLE 37. Japan Diabetes Therapeutics Market estimates & forecasts by segment 2018-2028 (USD Billion)
• TABLE 38. RoAPAC Diabetes Therapeutics Market estimates & forecasts, 2018-2028 (USD Billion)
• TABLE 39. RoAPAC Diabetes Therapeutics Market estimates & forecasts by segment 2018-2028 (USD Billion)
• TABLE 40. RoAPAC Diabetes Therapeutics Market estimates & forecasts by segment 2018-2028 (USD Billion)
• TABLE 41. Brazil Diabetes Therapeutics Market estimates & forecasts, 2018-2028 (USD Billion)
• TABLE 42. Brazil Diabetes Therapeutics Market estimates & forecasts by segment 2018-2028 (USD Billion)
• TABLE 43. Brazil Diabetes Therapeutics Market estimates & forecasts by segment 2018-2028 (USD Billion)
• TABLE 44. Mexico Diabetes Therapeutics Market estimates & forecasts, 2018-2028 (USD Billion)
• TABLE 45. Mexico Diabetes Therapeutics Market estimates & forecasts by segment 2018-2028 (USD Billion)
• TABLE 46. Mexico Diabetes Therapeutics Market estimates & forecasts by segment 2018-2028 (USD Billion)
• TABLE 47. RoLA Diabetes Therapeutics Market estimates & forecasts, 2018-2028 (USD Billion)
• TABLE 48. RoLA Diabetes Therapeutics Market estimates & forecasts by segment 2018-2028 (USD Billion)
• TABLE 49. RoLA Diabetes Therapeutics Market estimates & forecasts by segment 2018-2028 (USD Billion)
• TABLE 50. Row Diabetes Therapeutics Market estimates & forecasts, 2018-2028 (USD Billion)
• TABLE 51. Row Diabetes Therapeutics Market estimates & forecasts by segment 2018-2028 (USD Billion)
• TABLE 52. Row Diabetes Therapeutics Market estimates & forecasts by segment 2018-2028 (USD Billion)
• TABLE 53. List of secondary sources, used in the study of global Diabetes Therapeutics Market
• TABLE 54. List of primary sources, used in the study of global Diabetes Therapeutics Market
• TABLE 55. Years considered for the study
• TABLE 56. Exchange rates considered

LIST OF FIGURES

List of figures

• FIG 1. Global Diabetes Therapeutics Market, research methodology
• FIG 2. Global Diabetes Therapeutics Market, market estimation techniques
• FIG 3. Global market size estimates & forecast methods
• FIG 4. Global Diabetes Therapeutics Market, key trends 2021
• FIG 5. Global Diabetes Therapeutics Market, growth prospects 2022-2028
• FIG 6. Global Diabetes Therapeutics Market, porters 5 force model
• FIG 7. Global Diabetes Therapeutics Market, pest analysis
• FIG 8. Global Diabetes Therapeutics Market, value chain analysis
• FIG 9. Global Diabetes Therapeutics Market by segment, 2018 & 2028 (USD Billion)
• FIG 10. Global Diabetes Therapeutics Market by segment, 2018 & 2028 (USD Billion)
• FIG 11. Global Diabetes Therapeutics Market by segment, 2018 & 2028 (USD Billion)
• FIG 12. Global Diabetes Therapeutics Market by segment, 2018 & 2028 (USD Billion)
• FIG 13. Global Diabetes Therapeutics Market by segment, 2018 & 2028 (USD Billion)
• FIG 14. Global Diabetes Therapeutics Market, regional snapshot 2018 & 2028
• FIG 15. North America Diabetes Therapeutics Market 2018 & 2028 (USD Billion)
• FIG 16. Europe Diabetes Therapeutics Market 2018 & 2028 (USD Billion)
• FIG 17. Asia pacific market 2018 & 2028 (USD Billion)
• FIG 18. Latin America Diabetes Therapeutics Market 2018 & 2028 (USD Billion)
• FIG 19. Global Diabetes Therapeutics Market, company market share analysis (2021)